HUP0500557A3 - Use of thiazole derivatives for preparing a medicine for protecting mitochondria - Google Patents

Use of thiazole derivatives for preparing a medicine for protecting mitochondria

Info

Publication number
HUP0500557A3
HUP0500557A3 HU0500557A HUP0500557A HUP0500557A3 HU P0500557 A3 HUP0500557 A3 HU P0500557A3 HU 0500557 A HU0500557 A HU 0500557A HU P0500557 A HUP0500557 A HU P0500557A HU P0500557 A3 HUP0500557 A3 HU P0500557A3
Authority
HU
Hungary
Prior art keywords
medicine
preparing
thiazole derivatives
protecting mitochondria
mitochondria
Prior art date
Application number
HU0500557A
Other languages
English (en)
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of HUP0500557A2 publication Critical patent/HUP0500557A2/hu
Publication of HUP0500557A3 publication Critical patent/HUP0500557A3/hu
Publication of HU229425B1 publication Critical patent/HU229425B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Detergent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Accessory Of Washing/Drying Machine, Commercial Washing/Drying Machine, Other Washing/Drying Machine (AREA)
  • Cleaning By Liquid Or Steam (AREA)
HU0500557A 2001-07-26 2002-07-25 Use of thiazole derivatives for preparing a medicine for protecting mitochondria HU229425B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0109979A FR2827772B1 (fr) 2001-07-26 2001-07-26 Utilisation de derives de thiazoles pour preparer un medicament destine a proteger les mitochondries
PCT/FR2002/002660 WO2003009843A1 (fr) 2001-07-26 2002-07-25 Utilisation de derives de thiazoles pour preparer un medicament destine a proteger les mithochondries

Publications (3)

Publication Number Publication Date
HUP0500557A2 HUP0500557A2 (hu) 2005-09-28
HUP0500557A3 true HUP0500557A3 (en) 2006-02-28
HU229425B1 HU229425B1 (en) 2013-12-30

Family

ID=8865922

Family Applications (2)

Application Number Title Priority Date Filing Date
HU0500484A HU228783B1 (en) 2001-07-26 2000-07-13 Dry cleaning apparatus and method capable of utilizing a siloxane solvent
HU0500557A HU229425B1 (en) 2001-07-26 2002-07-25 Use of thiazole derivatives for preparing a medicine for protecting mitochondria

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU0500484A HU228783B1 (en) 2001-07-26 2000-07-13 Dry cleaning apparatus and method capable of utilizing a siloxane solvent

Country Status (26)

Country Link
US (3) US7345066B2 (hu)
EP (1) EP1414447B1 (hu)
JP (1) JP4491229B2 (hu)
KR (1) KR20040030843A (hu)
CN (1) CN1533276B (hu)
AT (1) ATE333876T1 (hu)
AU (1) AU2002341008B8 (hu)
BR (1) BR0211423A (hu)
CA (1) CA2455635C (hu)
CY (1) CY1106212T1 (hu)
DE (1) DE60213424T2 (hu)
DK (1) DK1414447T3 (hu)
ES (1) ES2268099T3 (hu)
FR (1) FR2827772B1 (hu)
HK (1) HK1069326A1 (hu)
HU (2) HU228783B1 (hu)
IL (2) IL159548A0 (hu)
IS (1) IS2366B (hu)
MX (1) MXPA04000752A (hu)
NO (1) NO334797B1 (hu)
NZ (1) NZ530368A (hu)
PL (1) PL206706B1 (hu)
PT (1) PT1414447E (hu)
RU (1) RU2297832C2 (hu)
TW (1) TWI309568B (hu)
WO (1) WO2003009843A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291641B2 (en) * 1999-10-11 2007-11-06 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
US7101917B2 (en) 2003-04-14 2006-09-05 Hoffmann-La Roche Inc. Mitochrondrial permeability transition pore affinity labels and modulators
WO2008067863A2 (en) * 2006-10-24 2008-06-12 Congenia S.R.L. Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt
KR100970814B1 (ko) * 2009-06-01 2010-07-16 주식회사 동아지질 석션 드레인 공법에 사용되는 배수재 연결구
JP6958860B2 (ja) 2017-11-07 2021-11-02 学校法人自治医科大学 ミトコンドリアの機能障害の改善剤、及びミトコンドリアの機能障害に起因する疾患又は症状の予防又は治療薬、並びにそれらの用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914207A (en) * 1989-05-09 1990-04-03 Pfizer Inc. Arylthiazolylimidazoles
ES2095960T3 (es) * 1990-09-25 1997-03-01 Rhone Poulenc Rorer Int Compuestos que tienen propiedades antihipertensivas y antiisquemicas.
HU9502843D0 (en) * 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
FR2764889B1 (fr) * 1997-06-20 2000-09-01 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
AU8875398A (en) * 1997-08-29 1999-03-22 Proteus Molecular Design Ltd 1-amino-7-isoquinoline derivatives as serine protease inhibitors
US6518292B1 (en) * 1999-03-12 2003-02-11 Bristol-Myers Squibb Co. Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
EP1192132B1 (en) * 1999-06-14 2005-09-07 Eli Lilly And Company Serine protease inhibitors
TWI283577B (en) * 1999-10-11 2007-07-11 Sod Conseils Rech Applic Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof
FR2800615B1 (fr) * 1999-11-05 2002-05-03 Sod Conseils Rech Applic Produit comprenant au moins une substance inhibitrice des no synthases en association avec au moins une substance inhibitrice des phospholipases a2

Also Published As

Publication number Publication date
CN1533276B (zh) 2010-06-30
US20070185174A1 (en) 2007-08-09
IS7100A (is) 2004-01-09
CA2455635A1 (fr) 2003-02-06
JP2005500337A (ja) 2005-01-06
BR0211423A (pt) 2004-08-17
HK1069326A1 (en) 2005-05-20
CN1533276A (zh) 2004-09-29
HU0500484D0 (en) 2005-07-28
HU228783B1 (en) 2013-05-28
MXPA04000752A (es) 2004-04-20
PT1414447E (pt) 2006-12-29
US20040248885A1 (en) 2004-12-09
US7345066B2 (en) 2008-03-18
AU2002341008A1 (en) 2003-02-17
IL159548A (en) 2009-11-18
HUP0500557A2 (hu) 2005-09-28
RU2297832C2 (ru) 2007-04-27
NO20040280L (no) 2004-01-21
DK1414447T3 (da) 2006-11-27
JP4491229B2 (ja) 2010-06-30
US20080039451A1 (en) 2008-02-14
WO2003009843A1 (fr) 2003-02-06
ES2268099T3 (es) 2007-03-16
CY1106212T1 (el) 2011-06-08
NO334797B1 (no) 2014-05-26
AU2002341008B8 (en) 2007-08-09
NZ530368A (en) 2005-04-29
RU2004105653A (ru) 2005-04-10
TWI309568B (en) 2009-05-11
IL159548A0 (en) 2004-06-01
FR2827772B1 (fr) 2006-04-28
DE60213424T2 (de) 2007-08-23
HU229425B1 (en) 2013-12-30
FR2827772A1 (fr) 2003-01-31
EP1414447A1 (fr) 2004-05-06
IS2366B (is) 2008-06-15
ATE333876T1 (de) 2006-08-15
PL206706B1 (pl) 2010-09-30
CA2455635C (fr) 2011-05-31
HUP0500484A3 (en) 2005-09-28
DE60213424D1 (de) 2006-09-07
PL368315A1 (en) 2005-03-21
AU2002341008B2 (en) 2007-03-08
EP1414447B1 (fr) 2006-07-26
KR20040030843A (ko) 2004-04-09

Similar Documents

Publication Publication Date Title
IL213806A0 (en) Use of derivatives of n-phenylpiperazin-1-yl-acetamide for the preparation of a pharmaceutical compositions for treatment of diabetes related conditions
IL146634A0 (en) Thiazole and oxazole derivatives and their pharmaceutical use
PL372123A1 (en) Thiazole derivatives
IL161623A0 (en) Nicotin-or isonicotin benzothiazole derivatives
PL370978A1 (en) Benzothiazole derivatives
IL166150A0 (en) Apparatus for altering the body temperature of a patient
IL173008A0 (en) Pharmaceutical compositions containing a thiazole derivative and a cytotoxic agent and some novel thiazole derivatives
IL159765A0 (en) Aryl substituted thiazolidinone derivatives and pharmaceutical compositions containing the same
IL147939A0 (en) Oxazole and thiazole derivatives and pharmaceutical compositions containing the same
IL166058A0 (en) Novel thiophenylglycoside derivatives methods for production thereof medicaments comprising said compounds and use thereof
EP1408867A4 (en) BREAKING DEVICES FOR STABILIZING DENTAL MODELS
IL156988A0 (en) Pharmaceutical compositions containing epothilone derivatives
IL157128A0 (en) Pharmaceutical compositions containing epothilone derivatives
PL375964A1 (en) Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis
HUP0401694A3 (en) Crystal forms of a hydrochloride salt of a hydroxynorephedrine derivative, pharmaceutical compositions comprising thereof and use
AU2001292285A1 (en) Thiazole or oxazole derivatives
PL375416A1 (en) Thiazole derivatives
NO20015368D0 (no) Anvendelse av forbindelser omfattende en nitrogen-oksygen- heteroring
HUP0500557A3 (en) Use of thiazole derivatives for preparing a medicine for protecting mitochondria
PL367676A1 (en) Novel heterocyclic derivatives and medicinal use thereof
PL373947A1 (en) Benzothiazole derivatives
HK1078853A1 (en) A new process for the preparation of epothilone derivatives
IL158312A (en) Use of pyridoindolone derivatives for preparing anticancer medicines
AU2003242538A1 (en) Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug
HUP0204547A3 (en) Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: IPSEN PHARMA S.A.S., FR

Free format text: FORMER OWNER(S): SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.), FR

MM4A Lapse of definitive patent protection due to non-payment of fees